Sight Sciences Stock News

Sight Sciences (SGHT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Sight Sciences: Appeal Is Visually Increasing

The company is a newer player in the medical devices space.

Sight Sciences Inc (SGHT) shares closed today at 0.9% above its 52 week low of $17.20, giving the company a market cap of $823M. The stock is currently down 48.1% year-to-date, down 48.1% over the past 12 months, and down 48.1% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 35.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -412.0% The company's stock price performance over the past 12 months lags the peer average by -564.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Sight Sciences Inc (NASDAQ:SGHT)’s stock price dropped 2.8% during trading on Tuesday . The stock traded as low as $17.43 and last traded at $17.50. Approximately 488 shares were traded during trading, a decline of 100% from the average daily volume of 360,448 shares. The stock had previously closed at $18.00. Separately, Zacks Investment Research […]

The FDA has cleared Sight Sciences Inc''s (NASDAQ: SGHT ) TearCare System for meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED). The indication clears TearCare for applying localized heat therapy in adult patients with evaporative DED due to MGD when used with the manual expression of the meibomian glands. The TearCare System provides safe and effective localized heat therapy intended to help soften or liquify thickened meibum for effective gland clearance. Related content: Benzinga''s Full Full story available on Benzinga.com

The FDA has cleared Sight Sciences Inc's (NASDAQ: SGHT) TearCare System for meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED).  The indication clears TearCare for apply

Sight Sciences Inc (NASDAQ:SGHT) traded up 5.6% during trading on Monday . The company traded as high as $20.20 and last traded at $20.20. 1,690 shares changed hands during trading, a decline of 99% from the average session volume of 273,010 shares. The stock had previously closed at $19.13. Separately, Zacks Investment Research downgraded shares []

Sight Sciences Inc (NASDAQ:SGHT) shares traded down 6.3% on Thursday . The stock traded as low as $19.86 and last traded at $19.86. 497 shares traded hands during trading, a decline of 100% from the average session volume of 274,073 shares. The stock had previously closed at $21.20. Separately, Zacks Investment Research cut shares of []

Shares of Sight Sciences Inc (NASDAQ:SGHT) gapped up prior to trading on Friday . The stock had previously closed at $20.16, but opened at $21.50. Sight Sciences shares last traded at $20.81, with a volume of 456 shares trading hands. SGHT has been the topic of a number of research reports. Morgan Stanley assumed coverage []

Sight Sciences Inc. (NASDAQ:SGHT) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 9.33% to the previous days close as strong demand from buyers drove the stock to $20.16. Actively observing the price movement in the last trading, the stock closed the session at $18.44, falling within a range of $18.80 Sight Sciences Inc. (NASDAQ: SGHT): Overvalued In Comparison To Others? Read More »

Related Stocks: SGHT ,

Related Stocks: NTRA , MGNX , SLGC , RPID , SGHT , AMRS , LPTX , ISEE , CERE , EPIX , AVIR , APLS , SBTX , FRLN ,